Shire PLC (LON:SHP)‘s stock had its “overweight” rating reiterated by equities researchers at JPMorgan Chase & Co. in a research note issued on Monday.
SHP has been the subject of several other reports. Shore Capital restated a “buy” rating on shares of Shire PLC in a research note on Tuesday, August 30th. Deutsche Bank AG restated a “buy” rating and set a GBX 6,000 ($78.32) target price on shares of Shire PLC in a research note on Monday, September 19th. HSBC restated a “buy” rating and set a GBX 5,400 ($70.49) target price on shares of Shire PLC in a research note on Tuesday, September 13th. Goldman Sachs Group Inc. restated a “conviction-buy” rating and set a GBX 6,300 ($82.23) target price on shares of Shire PLC in a research note on Thursday. Finally, Liberum Capital restated a “buy” rating and set a GBX 5,500 ($71.79) target price on shares of Shire PLC in a research note on Monday, September 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of GBX 5,828 ($76.07).
Shares of Shire PLC (LON:SHP) opened at 4997.602539 on Monday. The stock has a 50 day moving average price of GBX 4,983.22 and a 200 day moving average price of GBX 4,511.67. Shire PLC has a 12-month low of GBX 2,707.19 and a 12-month high of GBX 5,377.00. The stock’s market capitalization is GBX 34.12 billion.
The business also recently disclosed a dividend, which will be paid on Friday, October 7th. Investors of record on Thursday, September 8th will be paid a dividend of GBX 3.51 ($0.05) per share. The ex-dividend date of this dividend is Thursday, September 8th. This represents a dividend yield of 0.07%.
In related news, insider Dominic Blakemore acquired 133 shares of the stock in a transaction that occurred on Friday, September 30th. The shares were acquired at an average price of GBX 5,010 ($65.40) per share, for a total transaction of £6,663.30 ($8,697.69).
Shire PLC Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.